PubRank

Debabrata Mukhopadhyay

Author PubWeight™ 150.79‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 International network of cancer genome projects. Nature 2010 20.35
2 Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 2012 8.31
3 Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent. Cancer Res 2008 2.20
4 Direct evidence for endothelial vascular endothelial growth factor receptor-1 function in nitric oxide-mediated angiogenesis. Circ Res 2006 2.12
5 Neuropilin-1 promotes cirrhosis of the rodent and human liver by enhancing PDGF/TGF-beta signaling in hepatic stellate cells. J Clin Invest 2010 2.06
6 Simvastatin reduces venous stenosis formation in a murine hemodialysis vascular access model. Kidney Int 2013 1.83
7 Neuropilin-1-mediated vascular permeability factor/vascular endothelial growth factor-dependent endothelial cell migration. J Biol Chem 2003 1.82
8 The use of microorganisms for the formation of metal nanoparticles and their application. Appl Microbiol Biotechnol 2005 1.81
9 Antiangiogenic properties of gold nanoparticles. Clin Cancer Res 2005 1.78
10 Nitric oxide promotes endothelial cell survival signaling through S-nitrosylation and activation of dynamin-2. J Cell Sci 2007 1.66
11 Proinflammatory functions of vascular endothelial growth factor in alloimmunity. J Clin Invest 2003 1.66
12 Myogenic Akt signaling regulates blood vessel recruitment during myofiber growth. Mol Cell Biol 2002 1.63
13 Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression. Blood 2009 1.61
14 Endothelial cell-specific chemotaxis receptor (ecscr) promotes angioblast migration during vasculogenesis and enhances VEGF receptor sensitivity. Blood 2010 1.55
15 New insights into pancreatic cancer-induced paraneoplastic diabetes. Nat Rev Gastroenterol Hepatol 2013 1.54
16 Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer. Adv Drug Deliv Rev 2009 1.54
17 Revealing the role of phospholipase Cβ3 in the regulation of VEGF-induced vascular permeability. Blood 2012 1.51
18 C terminus of RGS-GAIP-interacting protein conveys neuropilin-1-mediated signaling during angiogenesis. FASEB J 2006 1.50
19 Chemically modified peptides targeting the PDZ domain of GIPC as a therapeutic approach for cancer. ACS Chem Biol 2012 1.50
20 KDR stimulates endothelial cell migration through heterotrimeric G protein Gq/11-mediated activation of a small GTPase RhoA. J Biol Chem 2002 1.49
21 NHERF-2 maintains endothelial homeostasis. Blood 2012 1.47
22 Vascular endothelial growth factor and semaphorin induce neuropilin-1 endocytosis via separate pathways. Circ Res 2008 1.43
23 Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin. Cancer Cell 2005 1.37
24 Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis. J Nanobiotechnology 2007 1.37
25 Regulatory role of dynamin-2 in VEGFR-2/KDR-mediated endothelial signaling. FASEB J 2005 1.37
26 Effect of insulin deprivation on muscle mitochondrial ATP production and gene transcript levels in type 1 diabetic subjects. Diabetes 2007 1.36
27 Adrenomedullin is up-regulated in patients with pancreatic cancer and causes insulin resistance in β cells and mice. Gastroenterology 2012 1.34
28 Snrk-1 is involved in multiple steps of angioblast development and acts via notch signaling pathway in artery-vein specification in vertebrates. Blood 2008 1.32
29 Neuropilin-1 modulates p53/caspases axis to promote endothelial cell survival. PLoS One 2007 1.32
30 Effect of rapamycin alone and in combination with antiangiogenesis therapy in an orthotopic model of human pancreatic cancer. Clin Cancer Res 2004 1.31
31 Inhibition of vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis by the Kruppel-like factor KLF2. J Biol Chem 2005 1.31
32 Adventitial remodeling with increased matrix metalloproteinase-2 activity in a porcine arteriovenous polytetrafluoroethylene grafts. Kidney Int 2005 1.30
33 Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells. Blood 2009 1.29
34 Angiogenesis in atherogenesis. Arterioscler Thromb Vasc Biol 2006 1.28
35 The novel receptor tyrosine kinase Axl is constitutively active in B-cell chronic lymphocytic leukemia and acts as a docking site of nonreceptor kinases: implications for therapy. Blood 2010 1.26
36 VEGF exerts an angiogenesis-independent function in cancer cells to promote their malignant progression. Cancer Res 2012 1.21
37 Heterotrimeric G alpha q/G alpha 11 proteins function upstream of vascular endothelial growth factor (VEGF) receptor-2 (KDR) phosphorylation in vascular permeability factor/VEGF signaling. J Biol Chem 2003 1.21
38 Regulation of vascular endothelial growth factor receptor 2 trafficking and angiogenesis by Golgi localized t-SNARE syntaxin 6. Blood 2010 1.21
39 Increased shear stress with upregulation of VEGF-A and its receptors and MMP-2, MMP-9, and TIMP-1 in venous stenosis of hemodialysis grafts. Am J Physiol Heart Circ Physiol 2008 1.20
40 Neuropilin-1 upholds dedifferentiation and propagation phenotypes of renal cell carcinoma cells by activating Akt and sonic hedgehog axes. Cancer Res 2008 1.19
41 Neuropilin-1 stimulates tumor growth by increasing fibronectin fibril assembly in the tumor microenvironment. Cancer Res 2012 1.19
42 Neuropilin-1 mediates divergent R-Smad signaling and the myofibroblast phenotype. J Biol Chem 2010 1.16
43 The rat femoral arteriovenous fistula model: increased expression of matrix metalloproteinase-2 and -9 at the venous stenosis. J Vasc Interv Radiol 2008 1.13
44 Multiinstitutional validation of the University of California at San Francisco Low-Grade Glioma Prognostic Scoring System. Clinical article. J Neurosurg 2009 1.12
45 Pancreatic stellate cell models for transcriptional studies of desmoplasia-associated genes. Pancreatology 2010 1.11
46 Expression and regulatory role of GAIP-interacting protein GIPC in pancreatic adenocarcinoma. Cancer Res 2006 1.11
47 Src homology 2 (SH2) domain containing protein tyrosine phosphatase-1 (SHP-1) dephosphorylates VEGF Receptor-2 and attenuates endothelial DNA synthesis, but not migration*. J Mol Signal 2008 1.11
48 Expression of hypoxia inducible factor-1 alpha, macrophage migration inhibition factor, matrix metalloproteinase-2 and -9, and their inhibitors in hemodialysis grafts and arteriovenous fistulas. J Vasc Interv Radiol 2008 1.09
49 Distinct role of PLCbeta3 in VEGF-mediated directional migration and vascular sprouting. J Cell Sci 2009 1.07
50 A functional family-wide screening of SP/KLF proteins identifies a subset of suppressors of KRAS-mediated cell growth. Biochem J 2011 1.07
51 Sclerostin binds and regulates the activity of cysteine-rich protein 61. Biochem Biophys Res Commun 2009 1.05
52 Ablation of peripheral dopaminergic nerves stimulates malignant tumor growth by inducing vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis. Cancer Res 2004 1.02
53 Flt-1-mediated down-regulation of endothelial cell proliferation through pertussis toxin-sensitive G proteins, beta gamma subunits, small GTPase CDC42, and partly by Rac-1. J Biol Chem 2001 1.02
54 Requirement of different signaling pathways mediated by insulin-like growth factor-I receptor for proliferation, invasion, and VPF/VEGF expression in a pancreatic carcinoma cell line. Biochem Biophys Res Commun 2003 1.02
55 Insulin receptor substrate-2 mediated insulin-like growth factor-I receptor overexpression in pancreatic adenocarcinoma through protein kinase Cdelta. Cancer Res 2009 1.01
56 Increased expression of hypoxia-inducible factor-1 alpha in venous stenosis of arteriovenous polytetrafluoroethylene grafts in a chronic renal insufficiency porcine model. J Vasc Interv Radiol 2008 1.01
57 Protein kinase C zeta transactivates hypoxia-inducible factor alpha by promoting its association with p300 in renal cancer. Cancer Res 2004 0.97
58 Designing nanoconjugates to effectively target pancreatic cancer cells in vitro and in vivo. PLoS One 2011 0.96
59 Hypoxia-induced phenotypic switch of fibroblasts to myofibroblasts through a matrix metalloproteinase 2/tissue inhibitor of metalloproteinase-mediated pathway: implications for venous neointimal hyperplasia in hemodialysis access. J Vasc Interv Radiol 2010 0.96
60 Targeting GIPC/synectin in pancreatic cancer inhibits tumor growth. Clin Cancer Res 2009 0.96
61 The neurotransmitter dopamine modulates vascular permeability in the endothelium. J Mol Signal 2008 0.96
62 Assessment of wall shear stress changes in arteries and veins of arteriovenous polytetrafluoroethylene grafts using magnetic resonance imaging. Cardiovasc Intervent Radiol 2006 0.96
63 DNA conjugated SWCNTs enter endothelial cells via Rac1 mediated macropinocytosis. Nano Lett 2012 0.95
64 Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cells in vivo. Int J Cancer 2012 0.95
65 The porcine remnant kidney model of chronic renal insufficiency. J Surg Res 2006 0.94
66 In vivo toxicity studies of europium hydroxide nanorods in mice. Toxicol Appl Pharmacol 2009 0.94
67 Absence of histologic retinal toxicity of intravitreal nanogold in a rabbit model. Retina 2008 0.93
68 Von Hippel-Lindau gene product modulates TIS11B expression in renal cell carcinoma: impact on vascular endothelial growth factor expression in hypoxia. J Biol Chem 2009 0.93
69 Precise scheduling of chemotherapy primes VEGF-producing tumors for successful systemic oncolytic virotherapy. Mol Ther 2011 0.92
70 Dopamine regulates phosphorylation of VEGF receptor 2 by engaging Src-homology-2-domain-containing protein tyrosine phosphatase 2. J Cell Sci 2009 0.91
71 Effects of pioglitazone versus glipizide on body fat distribution, body water content, and hemodynamics in type 2 diabetes. Diabetes Care 2006 0.91
72 Metformin suppresses pancreatic tumor growth with inhibition of NFκB/STAT3 inflammatory signaling. Pancreas 2015 0.91
73 Ephrin B2/EphB4 pathway in hepatic stellate cells stimulates Erk-dependent VEGF production and sinusoidal endothelial cell recruitment. Am J Physiol Gastrointest Liver Physiol 2010 0.91
74 RGS-GAIP-interacting protein controls breast cancer progression. Mol Cancer Res 2010 0.90
75 Role of elongin-binding domain of von Hippel Lindau gene product on HuR-mediated VPF/VEGF mRNA stability in renal cell carcinoma. Oncogene 2005 0.90
76 Adventitial transplantation of blood outgrowth endothelial cells in porcine haemodialysis grafts alleviates hypoxia and decreases neointimal proliferation through a matrix metalloproteinase-9-mediated pathway--a pilot study. Nephrol Dial Transplant 2008 0.90
77 Role of insulin receptor substrates and protein kinase C-zeta in vascular permeability factor/vascular endothelial growth factor expression in pancreatic cancer cells. J Biol Chem 2003 0.90
78 Endogenous vascular endothelial growth factor-A (VEGF-A) maintains endothelial cell homeostasis by regulating VEGF receptor-2 transcription. J Biol Chem 2011 0.89
79 Increased expression of a disintegrin and metalloproteinase thrombospondin 1 in thrombosed hemodialysis grafts. J Vasc Interv Radiol 2008 0.89
80 Reactive oxygen species driven angiogenesis by inorganic nanorods. Nano Lett 2011 0.88
81 CD40-induced transcriptional activation of vascular endothelial growth factor involves a 68-bp region of the promoter containing a CpG island. Am J Physiol Renal Physiol 2004 0.87
82 Vaccines targeting tumor blood vessel antigens promote CD8(+) T cell-dependent tumor eradication or dormancy in HLA-A2 transgenic mice. J Immunol 2012 0.87
83 Fetuin-A expression in early venous stenosis formation in a porcine model of hemodialysis graft failure. J Vasc Interv Radiol 2008 0.86
84 Protein kinase C-mediated modulation of FIH-1 expression by the homeodomain protein CDP/Cut/Cux. Mol Cell Biol 2007 0.85
85 Fabrication and characterization of an inorganic gold and silica nanoparticle mediated drug delivery system for nitric oxide. Nanotechnology 2010 0.85
86 Inhibition of GSK-3 induces differentiation and impaired glucose metabolism in renal cancer. Mol Cancer Ther 2013 0.84
87 Effect of hyperglycemia on human monocyte activation. J Investig Med 2011 0.83
88 A lipid-modified estrogen derivative that treats breast cancer independent of estrogen receptor expression through simultaneous induction of autophagy and apoptosis. Mol Cancer Res 2011 0.83
89 Tissue factor pathway inhibitor blocks angiogenesis via its carboxyl terminus. Arterioscler Thromb Vasc Biol 2012 0.83
90 Lanthanide phosphate nanorods as inorganic fluorescent labels in cell biology research. Clin Chem 2007 0.83
91 Role of AKT-glycogen synthase kinase axis in monocyte activation in human beings with and without type 2 diabetes. J Cell Mol Med 2009 0.83
92 Both vascular endothelial growth factor and soluble Flt-1 are increased in type 2 diabetes but not in impaired fasting glucose. J Investig Med 2010 0.82
93 Single-molecule detection of H₂O₂ mediating angiogenic redox signaling on fluorescent single-walled carbon nanotube array. ACS Nano 2011 0.82
94 VEGF neutralizing antibody increases the therapeutic efficacy of vinorelbine for renal cell carcinoma. J Cell Mol Med 2008 0.81
95 Lack of an effect of pioglitazone or glipizide on lipoprotein-associated phospholipase A2 in type 2 diabetes. Endocr Pract 2007 0.80
96 Inorganic phosphate nanorods are a novel fluorescent label in cell biology. J Nanobiotechnology 2006 0.80
97 Proteomic profiling in early venous stenosis formation in a porcine model of hemodialysis graft. J Vasc Interv Radiol 2008 0.80
98 Cytotoxicity of naphthoquinones and their capacity to generate reactive oxygen species is quenched when conjugated with gold nanoparticles. Int J Nanomedicine 2011 0.80
99 Wall shear stress measurement using phase contrast magnetic resonance imaging with phase contrast magnetic resonance angiography in arteriovenous polytetrafluoroethylene grafts. Angiology 2009 0.79
100 Von Hippel-Lindau gene product directs cytokinesis: a new tumor suppressor function. J Cell Sci 2011 0.79
101 Neuropilin-1 is expressed by chronic lymphocytic leukemia B cells. Leuk Res 2008 0.78
102 Structure-activity study to develop cationic lipid-conjugated haloperidol derivatives as a new class of anticancer therapeutics. J Med Chem 2011 0.78
103 Dopamine inhibits pulmonary edema through the VEGF-VEGFR2 axis in a murine model of acute lung injury. Am J Physiol Lung Cell Mol Physiol 2011 0.78
104 Sonochemically prepared BSA microspheres containing Gemcitabine, and their potential application in renal cancer therapeutics. Acta Biomater 2009 0.78
105 Selective assembly of DNA-conjugated single-walled carbon nanotubes from the vascular secretome. ACS Nano 2014 0.76
106 Growth factor mediated signaling in pancreatic pathogenesis. Cancers (Basel) 2011 0.76
107 Tumor angiogenesis 2012. J Oncol 2012 0.76
108 Regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF-A) expression in podocytes. Kidney Int 2004 0.76
109 Tumor angiogenesis. J Oncol 2010 0.76
110 Blood outgrowth endothelial cells reduce hypoxia-mediated fibroblast to myofibroblast conversion by decreasing proangiogenic cytokines. J Vasc Res 2015 0.75
111 A core-shell nanomaterial with endogenous therapeutic and diagnostic functions. Cancer Nanotechnol 2010 0.75
112 Chemically-Modified Peptides Targeting the PDZ Domain of GIPC as a Therapeutic Approach for Cancer. ACS Chem Biol 2015 0.75
113 Spatiotemporal intracellular nitric oxide signaling captured using internalized, near-infrared fluorescent carbon nanotube nanosensors. Nano Lett 2014 0.75